Baldo, Gerlie L.

HRN: 17-61-94  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/28/2023
CEFTRIAXONE 1G (VIAL)
03/28/2023
04/03/2023
IV
2g
OD
UTI
Waiting Final Action 
02/25/2024
CEFTRIAXONE 1G (VIAL)
02/25/2024
03/03/2024
PO
2g
OD
Fever, ETBD
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: